Recurrent venous thromboembolism in glioblastoma

Thrombosis Research

Volumn 137, Issue , 2016, Pages 184-188

  Edwin, Natasha Catherine ^a,d   Khoury, Michael N ^b,e,f   Sohal, Davendra ^c   McCrae, Keith R ^c   Ahluwalia, Manmeet S ^b   Khorana, Alok A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cancer associated thrombosis; Deep vein thrombosis; Glioblastoma multiforme; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; WARFARIN;

AGED; ANTIANGIOGENIC THERAPY; ANTICOAGULATION; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CEREBRAL SINUS THROMBOSIS; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT DISEASE; RISK FACTOR; SECOND CANCER; T CELL LYMPHOMA; TUMOR VOLUME; VENOUS THROMBOEMBOLISM; ADULT; AGE DISTRIBUTION; BRAIN TUMOR; CAUSALITY; COHORT ANALYSIS; COMORBIDITY; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; OHIO; PREVALENCE; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BRAIN NEOPLASMS; CAUSALITY; COHORT STUDIES; COMORBIDITY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OHIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84952639332     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.11.027     Document Type: Article

References (18)

1. J.R. Perry Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents Curr. Opin. Neurol. 23 2010 592 596
2. L.C. Marras, W.H. Geerts, and J.R. Perry The risk of venous thromboembolism is increased throughout the course of malignant glioma Cancer 89 2000 640 646
3. D.E. Gerber, S.A. Grossman, and M.B. Streiff Management of venous thromboembolism in patients with primary and metastatic brain tumors J. Clin. Oncol. 24 2006 1310 1318
4. J.R. Perry, J.A. Julian, N.J. Lapierriere, W. Geerts, G. Agnelli, L.R. Rogers, M.G. Malkin, R. Sawaya, R. Baker, A. Falanga, S. Parpia, T. Finch, and M.N. Levine PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophyloaxis in patients with newly diagnosed malignant glioma J. Thromb. Haemost. 8 2010 1959 1965
5. J.R. Perry Thromboembolic disease in patients with high-grade glioma Neuro-Oncology 14 2012 iv73 iv80
6. T.J. Semrad, R. O'Donnell, T. Wun, H. Chew, D. Harvey, H. Zhou, and R.H. White Epidemiology of venous thromboembolism in 9489 patients with malignant glioma J. Neurosurg. 106 2007 601 608
7. E. Pan, J.S. Tsai, and S.B. Mitchell Retrospective study of venous thromboembolic and intraceerebral hemorrhagic events in glioblastoma patients Anticancer Res. 29 2009 4309 4314
8. G.H. Lyman, A.A. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, E.P. Balaban, J.M. Clarke, C.R. Flowers, C.W. Francis, L.E. Gates, A.K. Kakkar, N.S. Key, M.N. Levine, H.A. Liebman, M.A. Tempero, S.L. Wong, M.R. Somerfield, and A. Falanga Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update J. Clin. Oncol. 31 2013 2189 2204
9. M.B. Streiff, X. Ye, T.S. Kickler, S. Desideri, J. Jani, J. Fisher, and S.A. Grossman A prospective multicenter study of venous thromboembolism in patients with newly diagnosed high grade glioma: hazard rate and risk factors J. Neuro-Oncol. 2015 10.1007/s11060-015-1840-z (Advance online publication)
10. S. Yust-Katz, J.J. Mandel, J. Wu, Y. Yuan, C.C. Webre, T.A. Pawar, H.S. Lhadha, M.R. Gilbert, and T.S. Armstrong Venous thromboemboliam and glioblastoma J. Neuro-Oncol. 124 2015 87 94
11. N. Magnus, E. D'Asti, D. Garnier, B. Meehan, and J. Rak Brain neoplasms and coagulation Semin. Thromb. Hemost. 39 2013 881 895
12. M.T. Sartori, A.D. Puppa, A. Ballin, G. Saggiorato, D. Bernardi, A. Padoan, R. Scienza, D. d'Avella, and G. Cella Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles J. Neuro-Oncol. 104 2011 225 231
13. A.K. Choucair, P. Silver, and V.A. Levin Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism J. Neurosurg. 66 1987 357 358
14. D. Schiff, and L.M. De Angelis Therapy of venous thromboembolism in patients with brain metastases Cancer 73 1994 493 498
15. J.M. Levin, D. Schiff, J.S. Loeffler, H.A. Fine, P.M. Black, and P.Y. Wen Complications of therapy for venous thromboembolic disease in patients with brain tumors Neurology 43 1993 1111 1114
16. A. Narayan, K. Hong, M. Streiff, R. Shinohara, C. Frangakis, J. Coresh, and H.S. Kim The impact of cancer on the clinical outcome of patients after inferior vena cava filter placement: a retrospective cohort study Am. J. Clin. Oncol. 2014 (epub ahead of print)
17. M.L. Louzada, M. Carrier, A. Lazo-Langner, V. Dao, M.J. Kovacs, T.O. Ramsy, M.A. Rodger, J. Zhang, A.Y. Lee, G. Meyer, and P.S. Wells Development of a clinical risk prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer associated venous thromboembolism Circulation 126 2012 448 454
18. R.M. Van Haren, E.J. Valle, C.M. Thorson, J.A. Guarch, J.M. Jouria, D.M. Andrews, D. Sleeman, J.U. Levi, A.S. Livingstone, and K.G. Proctor Long-term coagulation changes after resection of thoracoabdominal malignancies J. Am. Coll. Surg. 21 2014 846 855